Low zinc levels is associated with increased inflammatory activity but not with atherosclerosis, arteriosclerosis or endothelial dysfunction among the very elderly

BBA Clinical

Volumn 2, Issue , 2014, Pages 1-6

  De Paula, Rafaela C S ^b   Aneni, Ehimen C ^e   Costa, Ana Paula R ^b   Figueiredo, Valeria N ^a   Moura, Filipe A ^a   Freitas, Wladimir M ^a   Quaglia, Luiz A ^a   Santos, Simone N ^b   Soares, Alexandre A ^a   Nadruz, Wilson ^a   Blaha, Michael ^c   Blumenthal, Roger ^c   Agatston, Arthur ^d   Nasir, Khurram ^e   Sposito, Andrei C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Center for Prevention and Wellness   (United States)

Author keywords

Arteriosclerosis; Atherosclerosis; Endothelial dysfunction; Inflammation; Zinc

Indexed keywords

C REACTIVE PROTEIN;

AGED; ANTHROPOMETRY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; BODY MASS; BRACHIAL ARTERY REACTIVITY; CANCER STAGING; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINERAL INTAKE; QUESTIONNAIRE; VASODILATATION; VERY ELDERLY; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 84906737463     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2014.07.002     Document Type: Article

References (27)

1. Freitas W.M., Carvalho L.S., Moura F.A., Sposito A.C. Atherosclerotic disease in octogenarians: a challenge for science and clinical practice. Atherosclerosis 2012, 225:281-289.
2. Fraker P.J., King L.E. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 2004, 24:277-298.
3. Wellinghausen N., Rink L. The significance of zinc for leukocyte biology. J. Leukoc. Biol. 1998, 64:571-577.
4. Shankar A.H. Zinc and immune function: the biological basis of altered resistance to infection. Am. J. Clin. Nutr. 1998, 68:447S-463S.
5. Hennig B., Meerarani P., Ramadass P., Toborek M., Malecki A., Slim R., McClain C.J. Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition 1999, 15:744-748.
6. Khadilkar A.V., Chiplonkar S.A., Pandit D.S., Kinare A.S., Khadilkar V.V. Metabolic risk factors and arterial stiffness in Indian children of parents with metabolic syndrome. J. Am. Coll. Nutr. 2012, 31:54-62.
7. Vlachopoulos C., Aznaouridis K., Dima I., Ioakeimidis N., Vasiliadou C., Zervoudaki A., Gialernios T., Stefanadis C. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults. Int. J. Cardiol. 2007, 122:232-238.
8. Freitas W.M., Quaglia L.A., Santos S.N., Soares A.A., Japiassu A.V., Boaventura V., dos Santos Barros E., Cordova C., Nobrega O.T., Sposito A.C. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly. Atherosclerosis 2011, 216:212-216.
9. Smith R.A., Cokkinides V., Eyre H.J. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J. Clin. 2007, 57:90-104.
10. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. E. International Diabetes Federation Task Force on, Prevention, L. National Heart, I. Blood, A. American Heart, F. World Heart, S. International Atherosclerosis, O. International Association for the Study of, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
11. Costa A.P., de Paula R.C., Carvalho G.F., Araujo J.P., Andrade J.M., de Almeida O.L., de Faria E.C., Freitas W.M., Coelho O.R., Ramires J.A., Quinaglia e Silva J.C., Sposito A.C. High sodium intake adversely affects oxidative-inflammatory response, cardiac remodelling and mortality after myocardial infarction. Atherosclerosis 2012, 222:284-291.
12. Brazilian Table of Food Composition (TACO) Version 2 2006, NEPA-UNICAMP, Campinas.
13. Gottdiener J.S., Bednarz J., Devereux R., Gardin J., Klein A., Manning W.J., Morehead A., Kitzman D., Oh J., Quinones M., Schiller N.B., Stein J.H., Weissman N.J. E. American Society of, American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J. Am. Soc. Echocardiogr.: Off. Publ. Am. Soc. Echocardiogr. 2004, 17:1086-1119.
14. Juonala M., Jarvisalo M.J., Maki-Torkko N., Kahonen M., Viikari J.S., Raitakari O.T. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2005, 112:1486-1493.
15. Motoyama S., Sarai M., Harigaya H., Anno H., Inoue K., Hara T., Naruse H., Ishii J., Hishida H., Wong N.D., Virmani R., Kondo T., Ozaki Y., Narula J. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J. Am. Coll. Cardiol. 2009, 54:49-57.
16. Prasad A.S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:646-652.
17. Giannoglou G.D., Konstantinou D.M., Kovatsi L., Chatzizisis Y.S., Mikhailidis D.P. Association of reduced zinc status with angiographically severe coronary atherosclerosis: a pilot study. Angiology 2010, 61:449-455.
18. Murr C., Pilz S., Grammer T.B., Kleber M.E., Bohm B.O., Marz W., Fuchs D. Low serum zinc levels in patients undergoing coronary angiography correlate with immune activation and inflammation. J.Trace Elem. Med. Biol.: Organ. Soc. Miner. Trace Elem. 2012, 26:26-30.
19. Sesso H.D., Christen W.G., Bubes V., Smith J.P., MacFadyen J., Schvartz M., Manson J.E., Glynn R.J., Buring J.E., Gaziano J.M. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012, 308:1751-1760.
20. Journal N.B. NBJ's Supplement Business Report 2012 2012.
21. Bailey R.L., Gahche J.J., Lentino C.V., Dwyer J.T., Engel J.S., Thomas P.R., Betz J.M., Sempos C.T., Picciano M.F. Dietary supplement use in the United States, 2003-2006. J. Nutr. 2011, 141:261-266.
22. F.A.N.B. Institute of Medicine, Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001, National Academy Press, Washington, DC.
23. Honkanen V.E., Lamberg-Allardt C.H., Vesterinen M.K., Lehto J.H., Westermarck T.W., Metsa-Ketela T.K., Mussalo-Rauhamaa M.H., Konttinen Y.T. Plasma zinc and copper concentrations in rheumatoid arthritis: influence of dietary factors and disease activity. Am. J. Clin. Nutr. 1991, 54:1082-1086.
24. Foster M., Petocz P., Samman S. Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus. J. Nutr. Biochem. 2013, 24:1655-1661.
25. Noh H., Paik H.Y., Kim J., Chung J. The alteration of zinc transporter gene expression is associated with inflammatory markers in obese women. Biol. Trace Elem. Res. 2014, 160:153-154.
26. Liuzzi J.P., Lichten L.A., Rivera S., Blanchard R.K., Aydemir T.B., Knutson M.D., Ganz T., Cousins R.J. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6843-6848.
27. Ghayour-Mobarhan M., Taylor A., New S.A., Lamb D.J., Ferns G.A. Determinants of serum copper, zinc and selenium in healthy subjects. Ann. Clin. Biochem. 2005, 42:364-375.